XTX Topco Ltd Purchases Shares of 1,829 Danaher Co. (NYSE:DHR)

XTX Topco Ltd acquired a new stake in Danaher Co. (NYSE:DHR - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,829 shares of the conglomerate's stock, valued at approximately $420,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Norges Bank bought a new position in Danaher during the fourth quarter worth about $2,130,740,000. Raymond James Financial Inc. acquired a new position in shares of Danaher in the 4th quarter worth approximately $391,172,000. Van ECK Associates Corp lifted its position in shares of Danaher by 6,862.7% during the 4th quarter. Van ECK Associates Corp now owns 929,868 shares of the conglomerate's stock worth $213,452,000 after buying an additional 916,513 shares during the period. Parnassus Investments LLC boosted its stake in Danaher by 31.8% in the 4th quarter. Parnassus Investments LLC now owns 3,105,388 shares of the conglomerate's stock valued at $712,842,000 after buying an additional 749,136 shares in the last quarter. Finally, Proficio Capital Partners LLC grew its position in Danaher by 29,287.7% in the fourth quarter. Proficio Capital Partners LLC now owns 588,929 shares of the conglomerate's stock valued at $135,189,000 after acquiring an additional 586,925 shares during the period. Institutional investors own 79.05% of the company's stock.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of the business's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

DHR has been the topic of several recent analyst reports. Wells Fargo & Company reduced their target price on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Thursday, January 30th. Royal Bank of Canada reiterated an "outperform" rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday. Guggenheim restated a "buy" rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday. JPMorgan Chase & Co. cut their price objective on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Finally, The Goldman Sachs Group decreased their target price on Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a report on Wednesday. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $264.40.

Danaher Trading Up 0.4 %

Shares of NYSE:DHR traded up $0.87 during mid-day trading on Friday, reaching $197.37. The stock had a trading volume of 2,608,666 shares, compared to its average volume of 3,354,979. The firm has a 50 day simple moving average of $200.87 and a two-hundred day simple moving average of $223.98. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The firm has a market cap of $141.06 billion, a PE ratio of 37.38, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. On average, research analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Friday, March 28th were given a dividend of $0.32 per share. The ex-dividend date was Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. This is a positive change from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio (DPR) is currently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.